Ticker >

Bajaj Healthcare share price

Bajaj Healthcare Ltd.

NSE: BAJAJHCARE BSE: 539872 SECTOR: Pharmaceuticals & Drugs  53k   465   54

292.30
+2.35 (0.81%)
NSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 314

Today's Low

₹ 290.35

52 Week High

₹ 513.4

52 Week Low

₹ 275.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

806.7 Cr.

Enterprise Value

1203.31 Cr.

No. of Shares

2.76 Cr.

P/E

37.93

P/B

2.51

Face Value

₹ 5

Div. Yield

0.34 %

Book Value (TTM)

₹  116.55

CASH

17.72 Cr.

DEBT

414.33 Cr.

Promoter Holding

67.73 %

EPS (TTM)

₹  7.71

Sales Growth

-0.97%

ROE

12.36 %

ROCE

11.88%

Profit Growth

-39.73 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-0.97%
3 Year17.98%
5 Year18.39%

Profit Growth

1 Year-39.73%
3 Year19.46%
5 Year23.16%

ROE%

1 Year12.36%
3 Year24.93%
5 Year22.78%

ROCE %

1 Year11.88%
3 Year22.6%
5 Year21.4%

Debt/Equity

1.1268

Price to Cash Flow

-36.14

Interest Cover Ratio

3.53222908991261

CFO/PAT (5 Yr. Avg.)

0.283035388262249

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 67.73 0
Sep 2023 67.69 0
Jun 2023 67.49 0
Mar 2023 67.49 0
Dec 2022 67.42 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 17.9784941378935% for the Past 3 years.
  • Company has been maintaining healthy ROE of 24.9267278525088% over the past 3 years.
  • Company has been maintaining healthy ROCE of 22.5980037765% over the past 3 years.
  • The company has a high promoter holding of 67.73%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 6.36547057306107.

 Limitations

  • Company has negative cash flow from operations of -22.3237.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 132.57 158.44 129.74 101.21 108.57
Total Expenditure 102.14 139.39 107.99 82.26 89.04
Operating Profit 30.43 19.06 21.74 18.95 19.54
Other Income 0.07 0.72 0.22 1.22 0.8
Interest 5.37 7.36 8.75 8.26 6.65
Depreciation 4.43 7.42 6.31 6.66 7.35
Exceptional Items 0 0 0 0 0
Profit Before Tax 20.71 5 6.9 5.24 6.33
Tax 3.96 1.41 -0.12 0.12 0.8
Profit After Tax 16.75 3.59 7.03 5.12 5.52
Adjusted EPS (Rs) 6.07 1.3 2.55 1.86 2

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 325.02 410.01 656.98 679.89 673.29
Total Expenditure 282.09 361.73 520.62 561.23 566.33
Operating Profit 42.92 48.28 136.37 118.66 106.96
Other Income 0.97 6.53 6.91 1.44 1.6
Interest 8.32 6.63 8.34 12.78 22.99
Depreciation 11.41 12.12 16.12 17.64 27.35
Exceptional Items 0 0 0 0 0
Profit Before Tax 24.17 36.06 118.82 89.68 58.22
Tax 7.86 10.82 35.71 18.3 15.19
Net Profit 16.31 25.24 83.11 71.39 43.02
Adjusted EPS (Rs.) 5.91 9.14 30.11 25.87 15.59

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.9 13.8 13.8 13.8 13.8
Total Reserves 122.21 164.13 244.61 314.69 353.89
Borrowings 17.39 23.58 79.71 66.31 93.66
Other N/C liabilities 3.01 3.82 4.93 4.23 4.05
Current liabilities 117.34 137.61 182.57 322.07 436.06
Total Liabilities 266.85 342.95 525.63 721.1 901.46
Assets
Net Block 128.5 162.24 208.13 269.74 365.69
Capital WIP 1.18 5.45 57.05 51.98 20.34
Intangible WIP 0 0 0 0 1.39
Investments 0 5 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 1.84 2.12 1.07 4.3
Current Assets 137.17 168.42 258.33 398.31 509.74
Total Assets 266.85 342.95 525.63 721.1 901.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 24.17 36.06 118.82 89.68 58.22
Adjustment 20.06 15.54 24.48 31.47 55.89
Changes in Assets & Liabilities -6.04 -21.91 -64.09 -110.84 -124.89
Tax Paid -13.02 -9.12 -35.65 -9.63 -11.54
Operating Cash Flow 25.17 20.57 43.56 0.69 -22.32
Investing Cash Flow -13.03 -27.56 -108.93 -74.8 -93.43
Financing Cash Flow -12.57 3.28 75.46 61.85 131.5
Net Cash Flow -0.42 -3.7 10.08 -12.27 15.75

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 67.42 67.49 67.49 67.69 67.73
anil champalal jain 5.24 5.26 5.26 5.26 5.30
babita sajankumar bajaj 5.45 5.45 5.45 5.45 5.45
bajaj health & nutritions... 0.87 0.87 0.87 0.87 0.87
bansal pharma limited 0.22 0.22 0.22 0.22 0.22
namrata bajaj 5.90 5.91 5.91 5.91 5.91
nihita sajankumar bajaj 5.87 5.87 5.87 5.87 5.87
padma anil jain 1.10 1.10 1.10 1.10 1.10
s k r bajaj huf 7.83 7.83 7.83 7.83 7.83
sajankumar rameshwarlal b... 34.93 34.98 34.98 35.19 35.19
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 32.58 32.51 32.51 32.31 32.27
hetal chetan mehta - - - - 1.11
llp 0.36 0.58 0.37 0.22 0.07
maa sharda distributors p... 6.39 6.39 6.15 6.17 6.22
vls finance ltd 2.08 2.16 2.45 2.34 2.01
escorp asset management l... 1.72 1.72 1.72 - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ4FY22 1 Jul 2022
  • PresentationQ1FY21 18 Aug 2020

Company News

Bajaj Healthcare informs about trading window closure28 Mar 2024, 5:16PM Bajaj Healthcare informs about business updates28 Feb 2024, 3:06PM Bajaj Healthcare enters into definitive CDMO agreement with UK/EU based customers28 Feb 2024, 1:00PM Bajaj Healthcare - Quaterly Results9 Feb 2024, 8:07PM Bajaj Healthcare - Quaterly Results9 Feb 2024, 8:07PM Bajaj Healthcare informs about disclosures 17 Nov 2023, 12:18PM Bajaj Healthcare informs about earning updates13 Nov 2023, 4:06PM Bajaj Healthcare commissions Alkaloid Extraction Plant in Vadodara19 Oct 2023, 9:18AM Bajaj Healthcare completes construction of Alkaloid extraction Plant at Vadodara Unit 14 Oct 2023, 11:39AM Bajaj Healthcare gets EIR from USFDA for API manufacturing facility in Gujarat14 Sep 2023, 9:37AM Bajaj Healthcare informs about newspaper advertisement8 Sep 2023, 4:56PM Bajaj Healthcare informs about earning updates16 Aug 2023, 10:09AM Bajaj Healthcare - Quaterly Results14 Aug 2023, 12:00PM Bajaj Healthcare - Quaterly Results14 Aug 2023, 12:00PM Bajaj Healthcare - Quaterly Results30 May 2023, 7:58PM Bajaj Healthcare - Quaterly Results30 May 2023, 7:58PM Bajaj Healthcare - Quaterly Results13 Feb 2023, 5:48PM Bajaj Healthcare - Quaterly Results13 Feb 2023, 5:48PM Bajaj Healthcare informs about disclosure14 Dec 2022, 4:52PM Bajaj Healthcare commences trial runs for Opium Processing Business 23 Nov 2022, 3:47PM Bajaj Healthcare informs about disclosure 21 Nov 2022, 12:28PM USFDA completes pre-approval inspection at Bajaj Healthcare’s API facility in Gujarat18 Nov 2022, 12:25PM Bajaj Healthcare - Quaterly Results11 Nov 2022, 12:00PM Bajaj Healthcare - Quaterly Results11 Nov 2022, 12:00PM Bajaj Healthcare informs about press release3 Sep 2022, 3:28PM Bajaj Healthcare - Quaterly Results12 Aug 2022, 6:06PM Bajaj Healthcare - Quaterly Results12 Aug 2022, 6:06PM Bajaj Healthcare informs about clarification1 Aug 2022, 5:06PM Bajaj Healthcare informs about business updates13 Jul 2022, 10:48AM Bajaj Healthcare forays into highly regulated- Opiate Processing Business for GOI13 Jul 2022, 9:20AM Bajaj Healthcare - Quaterly Results17 May 2022, 6:06PM Bajaj Healthcare - Quaterly Results17 May 2022, 6:06PM Bajaj Healthcare to resume commercial production of Citicoline Sodium 11 May 2022, 3:18PM Bajaj Healthcare launches Magnesium L-Threonate in Nutraceutical segment 23 Feb 2022, 12:57PM Bajaj Healthcare informs about business update23 Feb 2022, 11:27AM Bajaj Healthcare informs about outcome of board meeting28 Jan 2022, 4:34PM Bajaj Healthcare informs about business updates24 Nov 2021, 11:04AM Bajaj Healthcare informs about press release20 Sep 2021, 10:17AM Bajaj Healthcare informs about proceedings of postal ballot18 Sep 2021, 3:03PM Bajaj Healthcare informs about newspaper publication9 Sep 2021, 5:06PM Bajaj Healthcare informs about AGM9 Sep 2021, 9:49AM Bajaj Healthcare informs about annual report8 Sep 2021, 12:55PM Bajaj Healthcare launches 2-Deoxy-D-Glucose formulation under 'DGJAJ' brand6 Sep 2021, 10:16AM Bajaj Healthcare informs about business updates3 Sep 2021, 10:00AM Bajaj Healthcare gets license from DRDO to manufacture and market '2-Deoxy-D-Glucose' 8 Jul 2021, 9:24AM Bajaj Healthcare launches ‘Posaconazole API’ used for treating Mucormycosis infection28 May 2021, 11:00AM Bajaj Healthcare launches Anti-Parasitic Drug ‘Ivermectin’ 6 May 2021, 11:21AM Bajaj Healthcare informs about business updates6 May 2021, 10:27AM Bajaj Healthcare launches antiviral drug ‘Favijaj’ 4 May 2021, 4:54PM Bajaj Healthcare informs about certificate27 Apr 2021, 3:46PM

Bajaj Healthcare Stock Price Analysis and Quick Research Report. Is Bajaj Healthcare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Bajaj Healthcare and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Bajaj Healthcare cash from the operating activity was Rs -22.3237 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Bajaj Healthcare has a Debt to Equity ratio of 1.1268 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Bajaj Healthcare , the EPS growth was -39.7301476842187 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Bajaj Healthcare has OPM of 15.8866435365339 % which is a good sign for profitability.
     
  • ROE: Bajaj Healthcare have a average ROE of 12.3601967896003 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Bajaj Healthcare is Rs 292.3. One can use valuation calculators of ticker to know if Bajaj Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Bajaj Healthcare
X